Detalles de la búsqueda
1.
Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum.
Alzheimers Dement
; 20(3): 1703-1715, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38088508
2.
A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.
Alzheimers Dement
; 20(2): 1239-1249, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975513
3.
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
Alzheimers Dement
; 20(1): 483-493, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37690071
4.
The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study.
Lancet Healthy Longev
; 5(4): e276-e286, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555920
5.
Plasma p-tau231 and p-tau217 as state markers of amyloid-ß pathology in preclinical Alzheimer's disease.
Nat Med
; 28(9): 1797-1801, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953717
6.
Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-ß pathology in preclinical Alzheimer's disease.
Nat Med
; 28(9): 1965, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100683
Resultados
1 -
6
de 6
1
Próxima >
>>